Tag Archives: Roshwalb
Akari Therapeutics, Plc [NASDAQ: AKTX]
Federman & Sherwood Announces the Filing of a Securities Class Action Lawsuit against Akari Therapeutics, Plc Oklahoma City, OK (May 15, 2017) – On May 12, 2017, a securities class action lawsuit was filed in the United States District Court for the Southern District of New York against Akari Therapeutics, Plc (NASDAQ: AKTX). The… Read More »